The World's Top 10 Most Dangerous Drugs The World's Top 10 Most Dangerous Drugs To Subscribe Our Channel Please Click Below Link: http://www.youtube.com/subscription_center?add_user=pastimers 1. He... By: pastimers … Continue reading →

Toxicology tests show that Adam Lanza had no alcohol or drugs in his body when he shot and killed 20 first-graders and six women at Sandy Hook Elementary School in Newtown on Dec. 14. The tests were conducted as part of the autopsy by state Chief Medical Examiner Dr. H. Wayne Carver II. Sources said his final report has been turned over to state prosecutors and investigators. Law enforcement sources familiar with the test results said that Lanza, 20, had no traces of alcohol or any illegal drugs such as cocaine or marijuana in his body. The sources also said that there is no trace of antidepressants or anti-psychotic medications. A toxicology exam searches for trace amount of hundreds of drugs from aspirin to antidepressants. Sources said testing for marijuana is a specific, separate test which Carver ordered in this case. It is unclear whether Lanza took medication or used illegal drugs or alcohol. Search warrant records released by state police do not indicate whether drugs or alcohol were found when investigators searched the Newtown home Lanza shared with his mother. Lanza shot and killed Nancy Lanza in the home before he went to the school. The warrants do indicate … Continue reading →

Matthew Marshall A DRUG syndicate mastermind and a former Albury detective each pleaded guilty yesterday to involvement with an ice ring uncovered by a coverted operation using phone taps. Matthew Louis Marshall served with the drug squad before leaving the force and becoming involved with Malcolm John Collins, who had many working for him distributing drugs. Collins, 44, appeared in Albury Local Court yesterday through a videolink from Cessnock jail. He pleaded guilty to a charge of supplying a commercial quantity of prohibited drug with the amount being 451.5 grams. Director of Public Prosecutions representative Diana Paterson deleted reference to a large commercial quantity and withdrew 16 other charges. Three fresh charges of supplying 134.85 grams of amphetamines, 1914 grams of cannabis and 10.3 grams of ecstasy between July 18 and October 10 last year will be considered when Collins appears for sentence in the District Court at Albury on August 5. Marshall, 42, of Albury, pleaded guilty to 13 supply charges mainly involving agreement to provide drugs, with another seven charges including indictable offences being withdrawn. Solicitor Paul Robb sought a two-week adjournment to finalise the facts relating to Marshalls offending. He remains on bail. The rest is here: … Continue reading →

Babies born addicted to prescription drugs are increasing in Tennessee the first state to track the number of babies born dependent on drugs. And a study published last year said more than 13,000 infants nationwide were affected in 2009. He's less than two weeks old, but he has the telltale signs of a baby in pain: a sore on his chin where he's rubbed the skin raw, along with a scratch on his cheek. He suffers from so many tremors that nurses watch him around the clock in case he starts seizing or stops breathing. Subscribe Today to the Monitor Click Here for your FREE 30 DAYS of The Christian Science Monitor Weekly Digital Edition The baby is one of many infants born dependent on drugs. He is being treated at East Tennessee Children's Hospital in Knoxville, where doctors and nurses are on the front lines fighting the nation's prescription drug epidemic. Drug abuse in the state is ranked among the nation's highest, according to some estimates. The hospital expects to treat 320 children this year for drug dependence, known as neonatal abstinence syndrome up from 33 in 2008. Last year, the hospital treated 283. "It blew us away," Andrew … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/ph8js4/generic_and) has announced the addition of the "Generic and Innovative Drugs Market in CIS Countries 2013 - Russia, Ukraine and Kazakhstan" report to their offering. Keep current with the changing CIS generic and innovative drug segments. Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015. Generic and innovative drug segments in CIS countries have played a huge role in supporting the pharmaceutical industry. Meanwhile, the effects of programmes such as Russia's Pharma 2020, Kazakhstan's GMP initiative and Ukraine's updated reimbursement structure are visible in the marketplace. How will issues like these influence market development in the next few years? How will they change pricing structures and reimbursement schemes? What are the rules regarding data exclusivity periods and drug patent viability? Stay informed with regard to these topics and many more by reviewing Generic and innovative drugs market in CIS countries 2013, Russia, Ukraine and Kazakhstan, Development forecasts for 2013-2015. This authoritative report is a single and complete source of market data, analysis and forecasts, combined to serve the needs of professionals with interests in the market. This PMR publication includes all relevant data concerning the size and value of the generic … Continue reading →

Merck & Co. (MRK), Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (ROG) have opened a new front against cancer with the next generation of experimental drugs that use the human immune system to seek and destroy tumor cells. The new therapies have the potential to reap billions of dollars in sales while lengthening patient remissions, said doctors and analysts awaiting study results to be released this week as part of the American Society of Clinical Oncology meeting that starts May 31. Building on the success of Bristol-Myers Yervoy drug for melanoma that reached the market in 2011, drugmakers are devising more potent immune therapies or combining treatments for maximum effectiveness. They are also testing the new medicines in more types of cancers, including lung and breast. If the new generation of immune therapies lives up to its promise, this is going to be a paradigm shift for treating cancer, said Merck senior vice president Gary Gilliland in an interview. We are pretty good at shrinking tumors, but not good at getting rid of them. Immune therapy is a way to begin to approach that. It will take at least a year before scientists will be able to determine whether … Continue reading →

SACRAMENTO Two of the nation's largest biotech companies Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a potential market worth tens of billions of dollars for pricey biological medicines they make from human blood, serums, bacterial cultures, viruses and other microorganisms. They are used to treat cancers, immune disorders and many other complex diseases. But now other drug manufacturers want to make and sell "biosimilars." These are drugs that would be similar to biological medicines but not identical like generic drugs. These biosimilar drugs would have to be certified by the U.S. Food and Drug Administration as "interchangeable" substitutes. The FDA has not yet spelled out how this would work. On Monday, the Senate Appropriations Committee will get a taste of the biosimilar debate. It will consider SB 598, a bill by Sen. Jerry Hill (D-San Mateo) to regulate the use of these injectable, biosimilar drugs. His legislation would enable doctors to restrict the use of biosimilars and require pharmacists to keep records of their dispensing. Hill said it's a matter of drug safety. "SB 598 allows … Continue reading →

Consumers should not buy sexual enhancement supplements, either online or in stores, because the products may contain undisclosed drugs that could cause serious harm, medical experts say. Although advertisements on sex supplements purport that the products improve sexual function, there is no evidence to support these claims, said Dr. Pieter Cohen, an assistant professor of medicine at Harvard Medical School and a general internist at Cambridge Health Alliance in Boston. In fact, there is no non-prescription product that has any proven benefit for helping with erections, Cohen said. Oftentimes manufacturers secretly add prescription drugs, such as sildenafil (sold under the brand name Viagra) or tadalafil (brand name Cialis), so that customers continue to use the products, Cohen said. Sometimes these undisclosed drugs are slightly modified versions of existing drugs, which are completely experimental and have not been shown to be safe, Cohen said. "These products either do not work, or if they do work, are potentially harmful," because they contain undisclosed drugs, Cohen said. In 2009, sex supplements tainted with high doses of diabetes medication caused more than 12 deaths in Asia. If doctors, lawmakers and legislatures don't act soon to reduce exposure to these supplements, more deaths could follow, … Continue reading →